Tag: Inavolisib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Inavolisib

Inavolisib Plus Palbociclib and Fulvestrant Improves PFS in PIK3CA-Mutated HR+ Breast Cancer

Added to Collection on: 2023-12-08 18:14:54

Tags for this article:

Aminopyridines
Protein kinase inhibitors
Breakthrough therapy
Amides
Palbociclib
Fulvestrant
Genentech
Breast cancer
HER2
Inavolisib
Buparlisib
Phosphoinositide 3-kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
HER2-Negative Breast Cancer Pipeline, FDA Approvals, Unmet - openPR.com

Added to Collection on: 2024-05-19 18:38:41

Tags for this article:

Antineoplastic drugs
Immunology
Breast cancer
HER2
Trastuzumab
CDK inhibitor
Genentech
Selective estrogen receptor degrader
Antibody-drug conjugate
Immutep
Inavolisib
Hormone receptor positive breast tumor
DelveInsight Business Research LLP

Click the tags to see associated articles and topics

View Article Details
FDA Grants Breakthrough Therapy Designation to Inavolisib for PIK3CA-Mutated Breast Cancer

Added to Collection on: 2024-05-21 20:36:23

Tags for this article:

Amides
Aminopyridines
Antineoplastic drugs
Specialty drugs
Cyclopentanes
Inavolisib
Phosphoinositide 3-kinase inhibitor
Palbociclib
Alpelisib
Breast cancer
Fulvestrant
P110α

Click the tags to see associated articles and topics

View Article Details
Roche announces phase III INAVO120 results were published | Markets Insider

Added to Collection on: 2024-10-31 19:45:26

Tags for this article:

Antiestrogens
Cyclopentanes
Lactams
Protein kinase inhibitors
Antineoplastic drugs
Inavolisib
Palbociclib
Fulvestrant
Genentech
Breast cancer
HER2
Roche

Click the tags to see associated articles and topics

View Article Details
Health Canada authorizes Itovebi® (inavolisib film-coated tablets), a targeted treatment for ...

Added to Collection on: 2025-02-20 00:51:07

Tags for this article:

Antineoplastic drugs
Cyclopentanes
Lactams
Selective estrogen receptor degraders
Breast cancer
Palbociclib
Inavolisib
P110α
Fulvestrant
Hormone receptor positive breast tumor
HER2
Alpelisib
HOFFMANN-LA ROCHE LIMITED

Click the tags to see associated articles and topics

View Article Details
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub

Added to Collection on: 2025-05-13 12:43:21

Tags for this article:

Protein kinase inhibitors
Cyclopentanes
Lactams
Specialty drugs
Antiestrogens
Palbociclib
Inavolisib
Fulvestrant
Genentech
Breast cancer
HER2
P110α

Click the tags to see associated articles and topics

View Article Details
Roche and Genentech Announce New North Carolina Manufacturing Facility | INN

Added to Collection on: 2025-05-12 19:37:42

Tags for this article:

Protein kinase inhibitors
Cyclopentanes
Lactams
Specialty drugs
Antiestrogens
Palbociclib
Inavolisib
Fulvestrant
Genentech
Breast cancer
HER2
P110α

Click the tags to see associated articles and topics

View Article Details
New Data Show Genentech's Itovebi Significantly Extended Survival in a Certain Type of HR ...

Added to Collection on: 2025-05-31 18:38:52

Tags for this article:

Cyclopentanes
Lactams
Protein kinase inhibitors
Selective estrogen receptor degraders
Antineoplastic drugs
Palbociclib
Fulvestrant
Inavolisib
Breast cancer
P110α
Alpelisib
Phosphoinositide 3-kinase inhibitor
Genentech
Itovebi
Roche Group

Click the tags to see associated articles and topics

View Article Details
New data show Roche's Itovebi significantly extended survival in - GuruFocus

Added to Collection on: 2025-05-31 12:25:33

Tags for this article:

Cyclopentanes
Lactams
Protein kinase inhibitors
Antineoplastic drugs
Palbociclib
Breast cancer
Inavolisib
P110α
Fulvestrant
HER2
Phosphoinositide 3-kinase inhibitor
Alpelisib

Click the tags to see associated articles and topics

View Article Details
New data show Roche's Itovebi significantly extended survival in a certain type of HR ...

Added to Collection on: 2025-06-01 00:38:31

Tags for this article:

Breast cancer
Antineoplastic drugs
Phosphoinositide 3-kinase inhibitor
Targeted therapy
Inavolisib
P110α
Phosphoinositide 3-kinase
HER2
Metastatic breast cancer
PI3K/AKT/mTOR pathway
Alpelisib
United States
Itovebi
Fulvestrant

Click the tags to see associated articles and topics

View Article Details
Book a Demo